Clover Health Investments Corp
CLOV.O- Latest Trade
- trading lower2.53USD
- Change
- -0.04
- % Change
1.36%Negative
- Day Range
- 2.50 - 2.62
- 52-Week Range
- 1.95 - 28.85
As of May 25 2022. Values delayed up to 15 minutes
- Previous Close
- 2.57
- Open
- 2.56
- Volume
- 2,453,521.00
- 3 Month Average Trading Volume
- 265.53
- Shares Out (Mil)
- 473.36
- Market Cap
- 1,301.75
- Forward P/E
- -3.49
- Dividend Yield
- -99,999.99
Key Statistics
3 mean rating - 6 analysts
- P/E Excl. Extra Items (TTM)
- -99,999.99
- Price To Sales (TTM)
- 0.61
- Price To Book (Quarterly)
- 2.65
- Price To Cash Flow (Per Share TTM)
- -99,999.99
- Total Debt/Total Equity (Quarterly)
- 4.07
- Long Term Debt/Equity (Quarterly)
- 4.07
- Return On Investment (TTM)
- -100.94
- Return On Equity (TTM)
- -34.66
2021 (millions USD)
About Clover Health Investments Corp
Company Information
Clover Health Investments, Corp. is a healthcare technology company. The Company’s segments include Medicare Advantage (MA) and Direct Contracting (DC). The MA segment is an insurance business model that focuses on leveraging the Clover Assistant at the point of care. The Company’s DC segment is similar to the cost management and care coordination model accounted for as a performance guarantee, where Clover is responsible for coordinating care, managing costs, and providing support to providers and their direct contracting entity (DCE) beneficiaries through the use of Clover Assistant. It offers a software platform called the Clover Assistant, which provides America’s seniors with Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans that are the obvious choice for Medicare-eligible consumers. The Clover Assistant is a technology platform that engages providers and delivers data-driven and personalized care. It operates its MA plans in over nine states.
Address
3401 Mallory Lane, Suite 210, Suite 320FRANKLIN, TN
37067
United States
Industry
Software & Programming
Latest News
- MarketsMosaic, Raytheon, Capri
U.S. stock indexes tumbled more than 1% on Monday as the prospect of a ban on oil imports from Russia sent crude prices soaring and fueled concerns about spiraling inflation.
- BusinessU.S. RESEARCH ROUNDUP Cognition Therapeutics, Mosaic, Shockwave Medical
Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cognition Therapeutics, Mosaic and Shockwave Medical on Wednesday.
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,865.10 | -- |
| Copper | 778.00 | 0.42%Negative |
| Brent Crude Oil | 113.70 | 0.12%Positive |
| CBOT Soybeans | 1,672.50 | 1.21%Negative |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 3,945.87 | 0.11%Positive |
| Euro STOXX 50 | 3,677.10 | 0.81%Positive |
| FTSE 100 | 7,522.75 | 0.51%Positive |
| Nikkei 225 | 26,677.80 | 0.26%Negative |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes